… an advantage of roxadustat compared with ESA treatment. … for roxadustat, supported by
the high treatment compliance … patients with CKD who are on peritoneal dialysis or not on …

… incidence rate, earlier onset and higher severity than other chronic kidney disease (CKD). …
on dialysis dependency and dialysis modalities. Fourth, the 3-month observational period was …

… This analysis demonstrates that roxadustat was noninferior to DA in correction of Hb levels
during the first 24 weeks of treatment in pts with NDD CKD stages 3-5 and anaemia. Safety …

… clinical practice for renal anemia in chronic kidney disease (CKD) patients on dialysis in 1990,
… The indication of roxadustat will be extended to patients at pre-dialysis stage by the end of …

… caused by chronic kidney disease. It can … of this paper is to study and analyze the short-term
efficacy of roxadustat in the treatment of renal anemia in patients with peritoneal dialysis. …

… of roxadustat in individuals with inflammation, and roxadustat … medication for treating
inflammatory people. PYRENEES was … of roxadustat in dialysis-dependent chronic kidney …

… has been the mainstay of treatment for anemia in chronic kidney disease (CKD). Although
… Roxadustat was also efficacious in incident dialysis patients who had not been treated with …

… of roxadustat in individuals with inflammation, and roxadustat could be an advantageous
medication for treating inflammatory people. … disease patients not on dialysis: a Phase 3, …

… analyses were performed based on whether patients were undergoing dialysis or not. …
KDIGO clinical practice guideline for anemia in chronic kidney disease. Kidney Int Suppl 279…

… the efficacy of Roxadustat in patients undergoing hemodialysis (HD). Nine patients under HD
(72±10 … It is well known that chronic kidney disease (CKD) is increasing worldwide. Renal …